CACardinal Health CAH · NYSE
$251.63 +0.83% (+$2.06)
- Market cap
- $58.3B
- Enterprise value
- $63.4B
- P/E
- 34.0x
- Forward P/E
- 19.6x
- PEG
- 3.5x
- P/S
- 0.2x
- P/FCF
- 12.9x
- EV/EBITDA
- 18.2x
- ROIC
- 13.2%
- Gross margin
- 3.8%
- Net margin
- 0.7%
- Dividend yield
- 0.82%
- Payout ratio
- 27.7%
- Net debt/EBITDA
- 1.5x
- Beta
- 0.50
- Free float
- 99.8%
About the company
Cardinal Health Inc. (CAH) is an American healthcare company specializing in the distribution of pharmaceutical and medical products. With an extensive network of distribution centers and logistics services, Cardinal Health ensures the efficient delivery of medications, medical supplies, and other healthcare materials to hospitals, pharmacies, and other healthcare facilities. The company is known for its ability to provide comprehensive supply chain management solutions, supporting the efficiency and quality of healthcare. Cardinal Health also invests in technology and innovation to enhance its logistics processes and customer service. Cardinal Health Inc. (CAH) shares could be suitable for investors looking for opportunities in the healthcare sector with a focus on the distribution and logistics of medical products.
Sector
Healthcare
Industry
Medical - Distribution
CEO
Jason Hollar
Employees
61,344
Headquarters
Dublin
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 79% a year over the last 3 years.
- What to watch: Earnings per share swing sharply from year to year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: It earns 13 USD a year on every 100 USD of invested capital.
- What to watch: Out of every 100 USD of revenue, only 0.7 USD is left as net profit.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 15 years in a row and pays out only 28% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number